UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-36732
  
PRA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
 
4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
(919) 786-8200
 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, $0.01 par value per share
(Title of each class of securities covered by this Form)
 
N/A
 (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
☒
 
Rule 12g-4(a)(2)
☐
 
Rule 12h-3(b)(1)(i)
☒
 
Rule 12h-3(b)(1)(ii)
☐
 
Rule 15d-6
☐
 
Rule 15d-22(b)
☐
 
Approximate number of holders of record as of the certification or notice date: Two

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, PRA Health Sciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.




PRA Health Sciences, Inc.




Date:
July 12, 2021

By:
/s/ Brendan Brennan




Name:
Brendan Brennan




Title:
Chief Financial Officer


PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more PRA Health Sciences Charts.
PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more PRA Health Sciences Charts.